Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Impact of a pharmacist-managed chemotherapy-induced anemia clinic

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: STEVENSON, James (University of Michigan Health System, Ann Arbor, Michigan, United States of America)
  • Co-author(s): Sutherland, Anna (University of Michigan Health System, ANN ARBOR, MICHIGAN, United States of America)
    Mackler, Emily (University of Michigan Health System, ANN ARBOR, MICHIGAN, United States of America)
    Dorsch, Michael (University of Michigan Health System, ANN ARBOR, MICHIGAN, United States of America)
    Huang, Jeffrey (University of Michigan College of Pharmacy, ANN ARBOR, United States of America)
  • Abstract:

    Erythropoietin stimulating agents (ESAs) are frequently used in the management of chemotherapy-induced anemia. The Food and Drug Administration (FDA) and the Center for Medicare and Medicaid Services (CMS) have created guidelines and reimbursement rules to improve the use of these drugs due to potential thromboembolic risk and impact on survival.

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses